|
NOL8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.015440E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.129200E-01 |
| Normal-vs-Stage2 |
3.737600E-01 |
| Normal-vs-Stage3 |
1.788050E-01 |
| Normal-vs-Stage4 |
6.707800E-02 |
| Stage1-vs-Stage2 |
3.311400E-01 |
| Stage1-vs-Stage3 |
1.847420E-01 |
| Stage1-vs-Stage4 |
4.198400E-02 |
| Stage2-vs-Stage3 |
9.083000E-01 |
| Stage2-vs-Stage4 |
3.720600E-01 |
| Stage3-vs-Stage4 |
3.411600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.451390E-01 |
| Normal-vs-AfricanAmerican |
3.639400E-01 |
| Normal-vs-Asian |
1.026160E-01 |
| Caucasian-vs-AfricanAmerican |
8.748400E-01 |
| Caucasian-vs-Asian |
6.171800E-01 |
| AfricanAmerican-vs-Asian |
5.800000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.816200E-01 |
| Normal-vs-Female |
1.159940E-02 |
| Male-vs-Female |
2.399900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.104000E-01 |
| Normal-vs-Extreme_Weight |
7.611600E-01 |
| Normal-vs-Obese |
1.256600E-01 |
| Normal-vs-Extreme_Obese |
5.497200E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.512000E-01 |
| Normal_Weight-vs-Obese |
5.463600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.379200E-01 |
| Extreme_Weight-vs-Obese |
1.919010E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.858000E-01 |
| Obese-vs-Extreme_Obese |
1.041040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.566550E-01 |
| Normal-vs-Age(41-60Yrs) |
1.315440E-03 |
| Normal-vs-Age(61-80Yrs) |
8.535200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.914000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.278200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.915800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.463760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.995800E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.620000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.168600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.237600E-02 |
| Normal-VS-Type2 PRCC |
9.388400E-01 |
| Normal-VS-KIRP CIMP |
2.372800E-01 |
| Normal-VS-Unclassified PRCC |
2.403000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.475200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.810000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.430000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.361000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.307800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.671200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.128600E-01 |
| Normal-vs-N1 |
5.279400E-03 |
| Normal-vs-N2 |
6.060600E-01 |
| N0-vs-N1 |
4.279700E-03 |
| N0-vs-N2 |
5.672200E-01 |
| N1-vs-N2 |
1.081990E-01 |
|
|
